vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and ZIPRECRUITER, INC. (ZIP). Click either name above to swap in a different company.

ZIPRECRUITER, INC. is the larger business by last-quarter revenue ($111.7M vs $75.5M, roughly 1.5× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 0.6%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $7.6M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -4.4%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

PBYI vs ZIP — Head-to-Head

Bigger by revenue
ZIP
ZIP
1.5× larger
ZIP
$111.7M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+27.1% gap
PBYI
27.7%
0.6%
ZIP
More free cash flow
PBYI
PBYI
$6.8M more FCF
PBYI
$14.4M
$7.6M
ZIP
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-4.4%
ZIP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
ZIP
ZIP
Revenue
$75.5M
$111.7M
Net Profit
$-835.0K
Gross Margin
69.3%
89.1%
Operating Margin
22.7%
3.6%
Net Margin
-0.7%
Revenue YoY
27.7%
0.6%
Net Profit YoY
92.3%
EPS (diluted)
$0.26
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
ZIP
ZIP
Q4 25
$75.5M
$111.7M
Q3 25
$54.5M
$115.0M
Q2 25
$52.4M
$112.2M
Q1 25
$46.0M
$110.1M
Q4 24
$59.1M
$111.0M
Q3 24
$80.5M
$117.1M
Q2 24
$47.1M
$123.7M
Q1 24
$43.8M
$122.2M
Net Profit
PBYI
PBYI
ZIP
ZIP
Q4 25
$-835.0K
Q3 25
$8.8M
$-9.8M
Q2 25
$5.9M
$-9.5M
Q1 25
$3.0M
$-12.8M
Q4 24
$-10.8M
Q3 24
$20.3M
$-2.6M
Q2 24
$-4.5M
$7.0M
Q1 24
$-4.8M
$-6.5M
Gross Margin
PBYI
PBYI
ZIP
ZIP
Q4 25
69.3%
89.1%
Q3 25
77.7%
89.1%
Q2 25
76.5%
89.3%
Q1 25
77.1%
89.4%
Q4 24
76.4%
89.6%
Q3 24
63.9%
89.4%
Q2 24
77.4%
89.5%
Q1 24
75.5%
89.1%
Operating Margin
PBYI
PBYI
ZIP
ZIP
Q4 25
22.7%
3.6%
Q3 25
17.6%
-4.4%
Q2 25
12.7%
-5.9%
Q1 25
8.7%
-10.6%
Q4 24
22.6%
-3.6%
Q3 24
27.4%
-2.8%
Q2 24
-4.6%
7.6%
Q1 24
-5.3%
-0.7%
Net Margin
PBYI
PBYI
ZIP
ZIP
Q4 25
-0.7%
Q3 25
16.2%
-8.5%
Q2 25
11.2%
-8.5%
Q1 25
6.5%
-11.7%
Q4 24
-9.7%
Q3 24
25.2%
-2.2%
Q2 24
-9.6%
5.7%
Q1 24
-11.0%
-5.3%
EPS (diluted)
PBYI
PBYI
ZIP
ZIP
Q4 25
$0.26
$-0.03
Q3 25
$0.17
$-0.11
Q2 25
$0.12
$-0.10
Q1 25
$0.06
$-0.13
Q4 24
$0.40
$-0.10
Q3 24
$0.41
$-0.03
Q2 24
$-0.09
$0.07
Q1 24
$-0.10
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
ZIP
ZIP
Cash + ST InvestmentsLiquidity on hand
$97.5M
$188.0M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$-77.2M
Total Assets
$216.3M
$569.7M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
ZIP
ZIP
Q4 25
$97.5M
$188.0M
Q3 25
$94.4M
$211.8M
Q2 25
$96.0M
$203.5M
Q1 25
$93.2M
$221.1M
Q4 24
$101.0M
$218.4M
Q3 24
$96.7M
$225.6M
Q2 24
$96.8M
$271.7M
Q1 24
$107.2M
$282.5M
Total Debt
PBYI
PBYI
ZIP
ZIP
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
ZIP
ZIP
Q4 25
$130.3M
$-77.2M
Q3 25
$115.3M
$-76.1M
Q2 25
$104.7M
$-65.9M
Q1 25
$97.1M
$-11.3M
Q4 24
$92.1M
$13.4M
Q3 24
$71.1M
$13.6M
Q2 24
$48.5M
$24.4M
Q1 24
$51.0M
$12.7M
Total Assets
PBYI
PBYI
ZIP
ZIP
Q4 25
$216.3M
$569.7M
Q3 25
$202.9M
$573.6M
Q2 25
$194.9M
$592.4M
Q1 25
$196.2M
$629.4M
Q4 24
$213.3M
$664.1M
Q3 24
$220.7M
$652.0M
Q2 24
$205.0M
$665.3M
Q1 24
$214.1M
$662.4M
Debt / Equity
PBYI
PBYI
ZIP
ZIP
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
ZIP
ZIP
Operating Cash FlowLast quarter
$14.4M
$7.7M
Free Cash FlowOCF − Capex
$14.4M
$7.6M
FCF MarginFCF / Revenue
19.1%
6.8%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
ZIP
ZIP
Q4 25
$14.4M
$7.7M
Q3 25
$9.7M
$2.6M
Q2 25
$14.1M
$10.5M
Q1 25
$3.6M
$-9.9M
Q4 24
$15.6M
$12.5M
Q3 24
$11.0M
$9.3M
Q2 24
$1.0M
$21.9M
Q1 24
$11.2M
$2.0M
Free Cash Flow
PBYI
PBYI
ZIP
ZIP
Q4 25
$14.4M
$7.6M
Q3 25
$9.7M
$2.2M
Q2 25
$14.1M
$10.2M
Q1 25
$3.6M
$-10.2M
Q4 24
$15.6M
$12.0M
Q3 24
$11.0M
$9.2M
Q2 24
$1.0M
$21.7M
Q1 24
$1.9M
FCF Margin
PBYI
PBYI
ZIP
ZIP
Q4 25
19.1%
6.8%
Q3 25
17.7%
1.9%
Q2 25
26.8%
9.1%
Q1 25
7.7%
-9.3%
Q4 24
26.4%
10.8%
Q3 24
13.7%
7.8%
Q2 24
2.1%
17.6%
Q1 24
1.6%
Capex Intensity
PBYI
PBYI
ZIP
ZIP
Q4 25
0.0%
0.1%
Q3 25
0.0%
0.3%
Q2 25
0.0%
0.3%
Q1 25
0.1%
0.3%
Q4 24
0.0%
0.4%
Q3 24
0.0%
0.2%
Q2 24
0.0%
0.1%
Q1 24
0.0%
0.1%
Cash Conversion
PBYI
PBYI
ZIP
ZIP
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
3.12×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

ZIP
ZIP

License$84.3M75%
Services$27.4M25%

Related Comparisons